The epidemiology of herpes simplex virus type 2 infections in a large cohort of HIV-infected patients, 2006-2014.

Michael Koren(Jacksonville University), Anuradha Ganesan(Henry M. Jackson Foundation), Robert Deiss, Thomas O’Bryan, José L. Sánchez, Jason M Blaylock, Jason F. Okulicz, Xun Wang, Grace Macalino, Tomas M. Ferguson, Brian K. Agan(Henry M. Jackson Foundation), Timothy J. Whitman, Tahaniyat Lalani(Henry M. Jackson Foundation)

PubMed

March 1, 2016

Cited by 3

Related Papers

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

|The Lancet|2017|196

TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study

|Gastroenterology|2021|177

Guidelines for the Prevention of Infections Associated With Combat-Related Injuries: 2011 Update

|The Journal of Trauma: Injury, Infection, and Critical Care|2011|133

SARS-CoV-2 BA.1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies

|Science Translational Medicine|2022|94

Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection

|JAMA Network Open|2023|91